Navigation Links
A protein called cFLIP makes tumor cells in breast cancer resistant to treatments
Date:12/14/2010

This release is available in Spanish.

Researchers at the Andalusian Institute for Molecular Biology and Regenerative Medicine (CABIMER) and the University of Granada found that cFLIP an inhibitor of death ligand-induced apoptosis is not only essential in breast tumor cells resistance to TRAIL treatments (a death ligand with a potent therapeutic potential against cancer), but this protein is also key to the survival of such cancer cells.

Researchers proved that a variation in the expression of this protein may lead to the normal development of breast epithelium. This is an important finding to be considered in the design of cFLIP-targeted therapies against cancer.

The research conducted by Rosario Yerbes Cadenas, PhD candidate at the University of Granada, was led by professor Abelardo Lpez Rivas, of CABIMER, and was aimed at analysing the potential of cFLIP inhibitors in cancer therapies.

At present, TRAIL is a death-ligand of the TNF family, with significant therapeutic potential against cancer, basically due to its ability to induce apoptosis in cancer cells without displaying significant toxicity toward normal cells. However, there are tumor cells that are resistant to TRAIL-induced apoptosis for unknown causes.

A Key Component

This study analysed the role of cFLIP in breast cancer cells' resistance to TRAIL-induced apoptosis. Thus, researchers concluded that cFLIP is key in these cells' resistance to TRAIL. Such conclusion was drawn from the evidence that the inhibition of their expression through treatments with Doxorubicin (anthracycline, widely used in chemotherapy) or with SAHA (Histone deacetylases inhibitor), as well as the silencing of its expression through cFLIP siRNA oligos (small interfering RNA), resulted in the sensitisati
'/>"/>

Contact: Rosario Yerbes Cadenas
Rosario.yerbes@cabimer.es
34-954-467-934
University of Granada
Source:Eurekalert

Page: 1 2

Related biology news :

1. Firefly protein lights pathway to improved detection of blood clots
2. Dynamics of chaperone protein critical in rescuing brains of Alzheimers mice from neuron damage
3. SomaLogic researchers describe revolutionary new approach to protein analysis and application to early diagnosis of lung cancer
4. Proteins, like people, act differently when crowded together
5. MIT biologists find that restoring the gene for cancer protein p53 slows spread of advanced tumors
6. Uptake protein acts as zincs doorway to the cell
7. Modulating a protein in the brain could help control Alzheimers disease
8. Process leading to protein diversity in cells important for proper neuron firing
9. A stem cell secreted protein can be given to improve heart function after experimental heart attack
10. Structure of a protein related to heart and nervous system health revealed
11. Synapses recycle proteins for the release of neurotransmitters
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2015)... 23, 2015 Aware, Inc. (NASDAQ: AWRE ), ... financial results for its second quarter ended June 30, 2015.  ... was $4.5 million, a decrease of 33% compared to $6.8 ... the second quarter of 2015 was $0.3 million, or $0.01 ... per diluted share, in the same period a year ago.  ...
(Date:7/21/2015)... July 21, 2015 Today, ZTE announced its ... as well as expected revenues in 2015 that relate to sales ... revenue guidance of approximately 2,200 MSEK for 2015. Jörgen ... leading smartphone manufacturer in China and we ... 02 5 for Axon , ...
(Date:7/21/2015)... NEW YORK , July 21, 2015 /PRNewswire/ ... critical systems, as seen in the recent U.S. ... enterprises a solution to the infosec conundrum, but ... data is stored. To address this dilemma, Biometrics-as-a-Service ... of its Biometric Tokenization SDK for third party ...
Breaking Biology News(10 mins):Aware, Inc. Reports Second Quarter 2015 Financial Results 2Aware, Inc. Reports Second Quarter 2015 Financial Results 3Aware, Inc. Reports Second Quarter 2015 Financial Results 4Aware, Inc. Reports Second Quarter 2015 Financial Results 5Aware, Inc. Reports Second Quarter 2015 Financial Results 6FPC's Touch Fingerprint Sensor FPC1025 in ZTE's Smartphone Axon 2HYPR Corp. Launches Industry First Biometric Tokenization Platform 2HYPR Corp. Launches Industry First Biometric Tokenization Platform 3HYPR Corp. Launches Industry First Biometric Tokenization Platform 4
... have left us with vivid images of the grasshopper ... Although commonly referred to as grasshoppers, the infestations were ... locust became extinct in 1902, but their cousins, grasshoppers ... billion (2005 U.S. dollars) in damage to grazing lands ...
... SAN ANTONIO, Texas, U.S.A. (Feb. 25, 2011) The death ... defect in diabetes. Scientists in Italy and Texas now have ... toxic imbalance of a molecule secreted by other pancreatic cells. ... can behave like adversaries for beta cells. This was an ...
... animals in the wild can be challenging, especially if ... giant panda or the clouded leopard. To remedy this, ... sensors. Left to photograph what passes in front of ... the behavior of animals around the world. The Smithsonian ...
Cached Biology News:Notre Dame research offers important clues about grasshopper population explosions 2Scientists find a new way insulin-producing cells die 2Candid cameras give a chance to see wildlife as a scientist does 2
(Date:7/30/2015)... Senomyx , Inc. (NASDAQ: SNMX ), a leading ... and commercialize novel flavor ingredients for the food, beverage, ... the second quarter 2015. "Moving into ... to achieve our commercial and financial goals," stated John ... "Since our last quarterly earnings report, our two partners ...
(Date:7/30/2015)... NY (PRWEB) , ... July 30, 2015 , ... As part of its 2015 growth ... material and technical service business units, Whitehouse Laboratories is pleased to announce ... be adjacent to the Container Center of Excellence and will be strictly dedicated to basic ...
(Date:7/29/2015)... , July 29, 2015 US-Australian drug ... ) today confirmed it is committed to progressing its ... soon as practicable and to ensure the Company delivers ... Executive Officer, Iain Ross , said the Company ... the lead pre-clinical programs, discovery programs and academic partnerships ...
(Date:7/29/2015)... TX (PRWEB) , ... July 29, 2015 , ... ... designer, manufacturer and supplier, announces the launch of their 2nd generation cell therapy ... the current miniPOD CT, but it also represents a new POD® design. ...
Breaking Biology Technology:SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 2SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 4SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 5SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 6SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 7SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 8SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 9Whitehouse Labs Formally Announces Plans to Open a Microbiological Laboratory 2Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 2Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 3Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 4Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 5Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 6Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 7Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 8Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 9Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 10G-CON Manufacturing Launches Their 2nd Generation Cell Therapy Cleanroom POD® 2G-CON Manufacturing Launches Their 2nd Generation Cell Therapy Cleanroom POD® 3
... ... been awarded the HPCwire,s Readers, Choice Award for Best Application of Green Computing. ... Conference (SC09), currently ongoing in Portland, Ore. , ... Portland, OR (Vocus) Nov. 17, 2009 --- The U.S. ...
... 17 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX:ONC, NASDAQ: ... updated results from a Phase I/II U.K. trial ... patients with advanced cancers in a poster presentation ... Therapeutics conference being held in Boston, Massachusetts. The ...
... LEIDEN, The Netherlands, November 17 Top Institute Pharma,(TI ... Medical Centre and Maastricht University to define ... and associated vascular,complications such as heart and kidney failure, ... drugs may be discovered with,the potential to prevent vascular ...
Cached Biology Technology:Argonne Recognized for "Green Computing" in 2009 HPCwire Readers' and Editors' Choice Awards 2Argonne Recognized for "Green Computing" in 2009 HPCwire Readers' and Editors' Choice Awards 3Argonne Recognized for "Green Computing" in 2009 HPCwire Readers' and Editors' Choice Awards 4Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase I/II Trial Results in Advanced Solid Cancers with a Focus on the Head and Neck at the AACR-NCI-EORTC Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase I/II Trial Results in Advanced Solid Cancers with a Focus on the Head and Neck at the AACR-NCI-EORTC Meeting 3New Consortium Paves the way for Improved Treatment of Hypertension and Associated Vascular Complications 2
alpha N-catenin (C-19)...
... AFFINITY PURIFIED GOAT ... ANTIBODY is conjugated with ... (RZ>3.0). The antibody ... solid-phase human, rat, fetal ...
Kanamycin is used for selection of resistant bacteria. C18H36N4O11xH2SO4. Contains 10 mg/ml kanamycin (base) utilizing kanamycin sulfate in 0.85% saline....
...
Biology Products: